European Urology
Volume 50, Issue 4 , Pages 844-850 , October 2006

Effect of Carbamazepine on Urinary Volume and Osmolality, Water Clearance, and Serum Osmolality in Patients with Primary Enuresis

  • Noori S. Al-Waili

      Affiliations

    • Al-Waili's Charitable Foundation for Science and Trading, New York, NY, USA
    • Corresponding Author InformationCorresponding author. New Technologies and Life Support Technologies, Chronic Wound Treatment and Hyperbaric Medicine Center, Mount Vernon Hospital, 7th Avenue 12 North, Mount Vernon, NY 10550, USA.
    • ,
  • Hamza Al-Waili

      Affiliations

    • Al-Waili's Charitable Foundation for Science and Trading, New York, NY, USA
    • ,
  • Khelod Y. Saloom

      Affiliations

    • Al-Waili's Charitable Foundation for Science and Trading, New York, NY, USA
    • ,
  • Thia Al-Waili

      Affiliations

    • Al-Waili's Charitable Foundation for Science and Trading, New York, NY, USA
    • ,
  • Ali Al-Waili

      Affiliations

    • Al-Waili's Charitable Foundation for Science and Trading, New York, NY, USA
    • ,
  • Mohammod Akmal

      Affiliations

    • Dubai Specialized Medical Center and Medical Research Laboratories, Islamic Establishment for Education, Dubai, UAE
    • ,
  • Faiza Al-Waili

      Affiliations

    • Dubai Specialized Medical Center and Medical Research Laboratories, Islamic Establishment for Education, Dubai, UAE

,Accepted 15 February 2006.

References 

  1. Herbert L, Jacson R, Fredin D, Breyer D. Evidences that separate PGE2 receptor modulate water and sodium transport in rabbit cortical collecting duct. Am J Physiol. 1993;265:F643–F652
  2. Maggi A. Prostanoid as local modulator of reflex micturition. Pharmacol Res. 1992;25:13–20
  3. Garcia H, Pomposiella I, Govin L. Nitric oxide inhibits ADH-stimulation osmotic water permeability in cortical collecting ducts. Am J Physiol. 1996;270:F206–F210
  4. Al-Waili N. Diclofenac sodium in the treatment of primary nocturnal enuresis: double-blind cross over study. Clin Exp Pharmacol Physiol. 1986;13:139–142
  5. Al-Waili N. Indomethacin suppository to treat primary nocturnal enuresis: double-blind study. J Urol. 1989;142:1290–1292
  6. Sener F, Hasanoglu E, Soylemezolgu O. Desmopressin versus indomethacin treatment in primary nocturnal enuresis and the role of prostaglandin. Urology. 1998;52:878–881
  7. Batislam E, Nuholu B, Peskirc O, Emir L, Uygur L. A prostaglandin synthesis inhibitor, diclofenac sodium in treatment of primary nocturnal enuresis. Acta Urol Bel. 1995;63:35–38
  8. Natochin V, Kuzentsova A. Nocturnal enuresis: correction of the renal function by desmopressin and diclofenac. Pediatr Nephrol. 2000;14:42–47
  9. AL-Waili N. Increased urinary nitrite excretion in primary enuresis: effects of indomethacin treatment on urinary and serum osmolality and electrolytes, urinary volumes and nitrite excretion. Br J Urol Int. 2002;90:294–301
  10. In:  Reynolds JEF editors. The extra pharmacopoeia. ed. 31. Martindale; 1996;
  11. Wojciech S, Wojciech K, Jolanta , Joanna O, Leszek B. A comparative study of vigabatrin vs. carbamazepine in monotherapy of newly diagnosed partial seizures in children. Pharm Report. 2005;57:646–653
  12. Matsufuji H, Ichiyama T, Isumi H, Furukawa S. Low-dose carbamazepine therapy for benign infantile convulsions. Brain Dev. 2005;27:554–557
  13. Ichiyama T, Matsufuji H, Suenaga N, Nishikawa M, Hayashi T, Furukawa S. Low-dose therapy with carbamazepine for convulsions associated with mild gastroenteritis. No To Hattatsu. 2005;37:493–497
  14. MacKintosh DA, Baird-Lampert J, Buchanan N. Is carbamazepine an alternative maintenance therapy for neonatal seizures?. Dev Pharmacol Ther. 1987;10:100–106
  15. Sillanapaa M. Carbamazepine. Pharmacology and clinical uses. Acta Neurol Scand. 1981;88:64
  16. Kuo C. A common anticonvulsant binding site for phenytoin, carbamazepine, and lamotrigine in neuronal Na+ channels. Mol Pharmacol. 1998;54:712–721
  17. McLean J, Macdonald L. Carbamazepine and 10,11-epoxycarbamazepine produce use- and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther. 1986;238:727–738
  18. Yoshimura R, Yanagihara N, Terao T. Inhibition by carbamazepine of various ion channels-mediated catecholamine secretion in cultured bovine adrenal medullary cells. Naunyn Schmiedebergs Arch Pharmacol. 1995;352:297–303
  19. Mizuno K, Okada M, Murakami T, Kamata A. Effects of carbamazepine on acetylcholine release and metabolism. Epilepsy Res. 2000;40:187–195
  20. Okada M, Hirano T, Mizuno K, Kawata Y. Effects of carbamazepine on hippocampal serotonergic system. Epilepsy Res. 1998;31:187–198
  21. Kawata Y, Okada M, Murakami T, Kamata A. Pharmacological discrimination between effects of carbamazepine on hippocampal basal, Ca2+- and K+-evoked serotonin release. Br J Pharmacol. 2001;133:557–567
  22. Matoth I, Pinto F, Sicsic C, Brenner T. Inhibitory effect of carbamazepine on inflammatory mediators produced by stimulated glial cells. Neurosci Res. 2000;38:209–212
  23. Ghelardoni S, Tomita YA, Bell JM, Rapoport SI, Bosetti F. Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain. Biol Psychiatry. 2004;56:248–254
  24. Tamura K, Yatabe Y, Sakamoto H, et al. Effects of carbamazepine on the first ovulation in gonadotropin-primed immature female rats. Br J Pharmacol. 2001;134:1328–1334
  25. Bianchi M, Rossoni G, Sacerdote P, Panerai AE, Berti F. Carbamazepine exerts anti-inflammatory effects in the rat. Eur J Pharmacol. 1995;294:71–74
  26. Afanas’ev I, Kudrin V, Rayevsky KS, Varga V, Saransaari P, Oja SS. Lamotrigine and carbamazepine affect differently the release of D-[3H]aspartate from mouse cerebral cortex slices: involvement of NO. Neurochem Res. 1999;24:1153–1159
  27. Al-Waili N. Carmbamazepine to treat primary nocturnal enuresis: double-blind study. Eur J Med Res. 2000;5:40–44
  28. Robert M, Averous M, Bessett A, Carlander B, Billiard M, Guiter J. Sleep polygraphic studies using cystomanometry in 20 patients with enuresis. Eur Urol. 1993;24:97–102
  29. Rittig S, Knudsen UB, Norgaard JP, Petersen EB, Djurhuus JC. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol. 1989;256:664–671
  30. Nørgaard JP, Pedersen EB, Djurhuus JC. Diurnal anti-diuretic-hormone levels in enuretics. J Urol. 1985;134:1029–1031
  31. Puri VN. Urinary levels of antidiuretic hormone in nocturnal enuresis. Indian Pediatr. 1980;17:675–676
  32. Nevéus T, Hetta J, Cnattingius S. Depth of sleep and sleep habits among enuretic and incontinent children. Acta Pediatr. 1999;88:748–752
  33. Yeung CK, Chiu HN, Sit FK. Bladder dysfunction in children with refractory monosymptomatic primary nocturnal enuresis. J Urol. 1999;162:1049–1054
  34. Stephans P, Baylis P. Plasma arginine-vasopressin concentration and antidiuretic action of carbamazepine. Br Med J. 1978;1:1445–1447
  35. Soelberg Sorensen P, Hammer M. Effects of long-term carbamazepine treatment on water metabolism and plasma vasopressin concentration. Eur J Clin Pharmcol. 1984;26:719–722
  36. Eggert P, Muller-Schluter K, Muller D. Regulation of arginine vasopressin in enuretic children under fluid restriction. Pediatrics. 1999;103:452–455
  37. Czako L, Laszlo FA. Antidiuretic effect of carbamazepine in diabetes insipidus. Int J Clin Pharmacol Biopharm. 1975;11:58–64

PII: S0302-2838(06)00240-5

doi: 10.1016/j.eururo.2006.02.040

European Urology
Volume 50, Issue 4 , Pages 844-850 , October 2006

Article Tools